Cite
APA Citation
Dervieux, T., Wallace, D. J., Putterman, C., Arriens, C., Kalunian, K. C., Massarotti, E. M., Alexander, R. V., Ibarra, C., Ramsey-Goldman, R., Weinstein, A., Narain, S., Saxena, A., Collins, C. E., Ahearn, J. M., & Manzi, S. (n.d.). 237 Cell bound complement activation products in combination with low complement C3 or C4 have high diagnostic yield in systemic lupus erythematosus. Lupus science & medicine, 6, A175–A176. http://access.bl.uk/ark:/81055/vdc_100144717515.0x000003